Page last updated: 2024-08-25

ranimustine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ranimustine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masaoka, T1
Adachi, T; Aoyama, S; Fukuda, S; Kitajima, K; Nakada, H; Ohmoto, E; Osada, K; Sanada, H; Takahashi, I; Yorimitsu, S1

Trials

1 trial(s) available for ranimustine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
[Ranimustine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:2

    Topics: Antineoplastic Agents; Busulfan; Drug Evaluation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Nitrosourea Compounds; Polycythemia Vera; Randomized Controlled Trials as Topic; Remission Induction

1990

Other Studies

1 other study(ies) available for ranimustine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
[Chemotherapy of chronic myelogenous leukemia--VP(M) regimen initiated during its chronic phase, and evaluation of MCNU in the phase of blastic crisis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11

    Topics: Adolescent; Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Drug Evaluation; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Male; Mercaptopurine; Middle Aged; Nitrosourea Compounds; Prednisolone; Remission Induction; Vincristine; Vindesine

1989